Orc integrates with NYSE Liffe's pre-trade price discovery platform - Cscreen
First Published 25th April 2012
Orc integrates with Cscreen to provide OTC pricing and reporting functionality
Stockholm - Orc has announced the integration of Orc Trading products with Cscreen, NYSE Liffe's pre-trade price discovery platform, providing traders with a method of interfacing Indications of Interests (IOIs) for equity and index derivatives from inter-dealer brokers (IDBs).
The Cscreen integration provides Orc users with a way to bring together their activities in the OTC equity derivatives markets alongside their on-screen trading. Leveraging Orc's functionality in strategy trading, the Cscreen solution aims to enable traders to price and assess any incoming IOIs for trading decisions. Traders can now employ an aggregated, comprehensive view of total trading risk in both listed and OTC markets.
"The integration with Cscreen is a natural extension of our electronic trading solutions allowing firms to more efficiently manage their OTC trading flows," said Jon Freebody, VP Sales at Orc. "As markets and regulations evolve, providing a tighter integration between OTC trading and electronic trading will allow firms to continue to grow their businesses."
"This exciting new initiative brings together two leading service providers," said Jason Lee, Head of Cscreen, NYSE Liffe. "Having more accurate information available in a more concise and aggregated view will give our customers the added benefit of a clearer and more informed platform on which to make trading decisions."